中国继续医学教育
中國繼續醫學教育
중국계속의학교육
China Continuing Medical Education
2015年
30期
164-165
,共2页
孙琳%潘秀霞%刘冬松%高飞%王兆芬
孫琳%潘秀霞%劉鼕鬆%高飛%王兆芬
손림%반수하%류동송%고비%왕조분
甲氨蝶呤%类风湿关节炎%肿瘤坏死因子拮抗剂%关节腔注射
甲氨蝶呤%類風濕關節炎%腫瘤壞死因子拮抗劑%關節腔註射
갑안접령%류풍습관절염%종류배사인자길항제%관절강주사
Methotrexate%Rheumatoid arthritis%Tumor necrosis factor
目的:比较关节腔注射肿瘤坏死因子拮抗剂与注射甲氨蝶呤针剂治疗类风湿关节炎的临床效果。方法随机抽取2012年2月~2015年2月在我院接受治疗的100例类风湿关节炎患者作为观察对象,根据治疗方法将患者随机分为两组,1组患者实施关节腔注射肿瘤坏死因子拮抗剂(依那西普)疗法,2组患者接受关节腔注射甲氨蝶呤针剂治疗,比较两组疗效。结果两组患者治疗期间,不良反应发生率未出现明显差异(P>0.05);1组总有效率高于2组,且1组治疗后关节活动程度、关节炎缓解程度优于2组,两组差异显著(P<0.05)。结论关节注射肿瘤坏死因子拮抗剂(依那西普)与注射甲氨蝶呤针剂均能够对类风湿关节炎患者发挥较好的治疗效果,且均会导致患者出现不同程度不良反应。但是,关节注射肿瘤坏死因子在关节活动程度及关节炎缓解程度上更具优势。
目的:比較關節腔註射腫瘤壞死因子拮抗劑與註射甲氨蝶呤針劑治療類風濕關節炎的臨床效果。方法隨機抽取2012年2月~2015年2月在我院接受治療的100例類風濕關節炎患者作為觀察對象,根據治療方法將患者隨機分為兩組,1組患者實施關節腔註射腫瘤壞死因子拮抗劑(依那西普)療法,2組患者接受關節腔註射甲氨蝶呤針劑治療,比較兩組療效。結果兩組患者治療期間,不良反應髮生率未齣現明顯差異(P>0.05);1組總有效率高于2組,且1組治療後關節活動程度、關節炎緩解程度優于2組,兩組差異顯著(P<0.05)。結論關節註射腫瘤壞死因子拮抗劑(依那西普)與註射甲氨蝶呤針劑均能夠對類風濕關節炎患者髮揮較好的治療效果,且均會導緻患者齣現不同程度不良反應。但是,關節註射腫瘤壞死因子在關節活動程度及關節炎緩解程度上更具優勢。
목적:비교관절강주사종류배사인자길항제여주사갑안접령침제치료류풍습관절염적림상효과。방법수궤추취2012년2월~2015년2월재아원접수치료적100례류풍습관절염환자작위관찰대상,근거치료방법장환자수궤분위량조,1조환자실시관절강주사종류배사인자길항제(의나서보)요법,2조환자접수관절강주사갑안접령침제치료,비교량조료효。결과량조환자치료기간,불량반응발생솔미출현명현차이(P>0.05);1조총유효솔고우2조,차1조치료후관절활동정도、관절염완해정도우우2조,량조차이현저(P<0.05)。결론관절주사종류배사인자길항제(의나서보)여주사갑안접령침제균능구대류풍습관절염환자발휘교호적치료효과,차균회도치환자출현불동정도불량반응。단시,관절주사종류배사인자재관절활동정도급관절염완해정도상경구우세。
Objective Compare the articular cavity injection of tumor necrosis factor antagonists and methotrexate injection for treatment of rheumatoid arthritis.Methods Randomly in February 2012 to February 2015 in our hospital for treatment of 100 patients with rheumatoid arthritis as research object, according to treatment the patients were randomly divided into two groups, one group of patients implement articular cavity injection of tumor necrosis factor antagonists (according to the heap) treatment, 2 groups of patients with articular cavity injection of methotrexate injection treatment, compared two groups of curative effect. ResultsTwo groups of patients during treatment, the incidence of adverse drug reactions does not appear obvious difference (P>0.05), 1 group total effective rate was obviously higher than 2, and 1 set of joints, arthritis relieved after treatment was significantly better than 2 group, significant difference was found in two groups (P<0.05).Conclusion Joint injection of tumor necrosis factor antagonists (etanercept) and methotrexate injection can play a good therapeutic effect in patients with rheumatoid arthritis, and will lead to different degree of adverse reactions to patients. But, joint injection of tumor necrosis factor in relief extent joint activity degree and arthritis.